Department Of Cardiology 9
401. Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
402. Metabolically healthy obesity: Misleading phrase or healthy phenotype?
403. A two-stage approach to correct aortic coarctation combined with aortic root aneurysm and bicuspid aortic valve in an adult patient
404. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
405. Pregnancy outcomes in women after arterial switch operation for transposition of the great arteries: Results from ropac (registry of pregnancy and cardiac disease) of the european society of cardiology eurobservational research programme
406. Pregnancy outcomes in women after arterial switch operation for transposition of the great arteries: Results from ropac (registry of pregnancy and cardiac disease) of the european society of cardiology eurobservational research programme
407. Pregnancy outcomes in women after arterial switch operation for transposition of the great arteries: Results from ropac (registry of pregnancy and cardiac disease) of the european society of cardiology eurobservational research programme
408. Pathogenetic justification of digestive tract dysfunction correction to reduce the risk of ventricular extrasystoles after coronary bypass grafting
409. Pathogenetic justification of digestive tract dysfunction correction to reduce the risk of ventricular extrasystoles after coronary bypass grafting
410. 2021 ESC/EACTS Guidelines for the management of valvular heart disease
411. 2021 ESC/EACTS Guidelines for the management of valvular heart disease
412. 2021 ESC/EACTS Guidelines for the management of valvular heart disease
413. 2021 ESC/EACTS Guidelines for the management of valvular heart disease
414. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
415. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
416. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
417. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
418. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
419. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
420. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
421. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
422. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
423. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
424. Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government
425. Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government
426. The fourth report of the European Registry for Patients with Mechanical Circulatory Support (EUROMACS) of the European Association for Cardiothoracic Surgery: focus on standardized outcome ratios
427. The fourth report of the European Registry for Patients with Mechanical Circulatory Support (EUROMACS) of the European Association for Cardiothoracic Surgery: focus on standardized outcome ratios
428. The fourth report of the European Registry for Patients with Mechanical Circulatory Support (EUROMACS) of the European Association for Cardiothoracic Surgery: focus on standardized outcome ratios
429. The fourth report of the European Registry for Patients with Mechanical Circulatory Support (EUROMACS) of the European Association for Cardiothoracic Surgery: focus on standardized outcome ratios
430. Assessment of frailty in patients with heart failure: A new Heart Failure Frailty Score developed by Delphi consensus
431. Assessment of frailty in patients with heart failure: A new Heart Failure Frailty Score developed by Delphi consensus
432. Assessment of frailty in patients with heart failure: A new Heart Failure Frailty Score developed by Delphi consensus
433. Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry
434. Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry
435. Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry
436. Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology
437. Quality of life in heart failure. the heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology
438. 2024 ESC Guidelines for the management of chronic coronary syndromes
439. 2024 ESC Guidelines for the management of chronic coronary syndromes
440. 2024 ESC Guidelines for the management of chronic coronary syndromes
441. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019
442. Physical Activity, Screen Time, and Sleep Duration of Children Aged 6-9 Years in 25 Countries: An Analysis within the WHO European Childhood Obesity Surveillance Initiative (COSI) 2015-2017
443. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
444. Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity?
445. Assessing atrial fibrillation–related quality of life improvements one year after ablation: A systematic review and meta-analysis.
446. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
447. ACUTE FORMS OF CORONARY ARTERY DISEASE IN THE NOSOLOGICAL STRUCTURE OF HOSPITALIZATION OF YOUNG PEOPLE IN ALMATY CITY CARDIOLOGY CENTER
1 7 8 9 9